Key result
Post-PCI LV remodeling linked to ~3.5-fold higher major cardiovascular events risk only with incomplete revascularization.
Why the study?
The study sought to identify factors related to left ventricular remodeling and evaluate its prognostic impact in STEMI patients with multivessel disease treated with complete versus incomplete revascularization.
Does the development of left ventricular remodeling within the first year after PCI impact long-term major adverse cardiovascular outcomes differently according to complete versus incomplete revascularization in patients with STEMI and multivessel disease?
Cohort (n=262)
No
Does the development of left ventricular remodeling within the first year after PCI impact long-term major adverse cardiovascular outcomes differently according to complete versus incomplete revascularization in patients with STEMI and multivessel disease?
In patients with STEMI and multivessel disease, developing left ventricular remodeling within the first year post-PCI predicts worse long-term MACE and heart failure hospitalization only when revascularization is incomplete, suggesting a protective effect of complete revascularization.
Answers are grounded in this paper and cite their sources.
LV remodeling may warrant targeted monitoring only after incomplete revascularization; leaves open whether complete revascularization mitigates remodeling-related risk.
In this study, we identified several factors related to left ventricular remodeling (LVR) and examined the impact of LVR on the prognosis of patients with ST-elevated myocardial infarction and multivessel disease treated with complete (CR) or incomplete (IR) revascularization. LVR was defined as an LV end-diastolic diameter >55 mm. A total of 262 patients without LVR at presentation were followed up with echocardiography between 1 month and 1 year. The primary outcome was a composite of all-cause death (AD), MI, and heart failure (HF), referred to as a major adverse cardiovascular endpoint (MACE). Then, each variable was analyzed as a secondary outcome. Follow-up echocardiography identified 26 patients (9.9%) with LVR. LVR was associated with an initial LV ejection fraction <50%, Killip 3 disease at presentation, and a peak troponin I level >70 mg/dL. Survival analysis showed an association between LVR and adverse outcomes only in the IR group, in which the adjusted hazard ratio (HR) was increased for the MACE (HR = 3.22, 95% confidence interval (CI) = 1.19−8.71, p = 0.002) and HF (HR = 21.37, 95% CI = 4.47−102.09, p< 0.001), but not for the CR group. In STEMI with MVD, LVR within the first year after percutaneous coronary intervention was associated with worse outcomes in the IR but not the CR group.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2022) conducted a cohort in ST-elevation myocardial infarction (STEMI) with multivessel disease (MVD) (n=262). Left ventricular remodeling (LVEDD > 55 mm) within 1 year after PCI vs. No left ventricular remodeling (LVEDD ≤ 55 mm) was evaluated on Major adverse cardiovascular endpoint (MACE: composite of all-cause death, recurrent MI, and readmission due to heart failure) in the incomplete revascularization subgroup (HR 3.51, 95% CI 1.34-9.18, p=0.010). Left ventricular remodeling after PCI for STEMI with multivessel disease increased major cardiovascular events risk in incomplete revascularization but not in complete revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: